Delivery Order SPE2DB20D3101-SPE2DB25FRSR3
Award Date 8/14/25
Potential Completion Date 9/5/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $3,436.96 delivery order to AmerisourceBergen Drug Corp for ENVARSUS XR 1 mg tablets (100-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. ENVARSUS XR is a tacrolimus-based immunosuppressant medication used primarily to prevent organ rejection in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (30-count supply) valued at $3,106.80, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release formulation of tacrolimus, an immunosuppressant medication commonly used in...
- The Defense Logistics Agency awarded a $1,165.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENVARSUS XR 1 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 22, 2025. This non-competitive set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, holds a substantial...
- This is a $1,169.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a vehicle for...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp in the amount of $1,615.33 for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying this critical medication under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- This is a $1,615.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare providers. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of ENVARSUS XR 0.75 MG TABLET 100S. The contract has a ceiling value of $1,933.80 and an ultimate completion date of July 17, 2025. This order is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a comprehensive...
- This is a $3,106.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a prescription medication, to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not set-aside and is associated with a larger $999,999,999.00 Indefinite...
- This is a $1,933.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENVARSUS XR 0.75 MG TABLET 100S, a pharmaceutical product, with a period of performance through March 14, 2025. This delivery order is placed against AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,361.58 for Envarsus XR 1 mg tablets (30-count supply) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release immunosuppressant medication used primarily in...